Skip to main navigation Skip to search Skip to main content

Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1153-1159
JournalAnnals of the rheumatic diseases
Volume70
Issue number6
DOIs
Publication statusPublished - 2011

Cite this